MSA-FLUO

Fluoxetine for the Symptomatic Treatment of Multiple System Atrophy: The MSA-FLUO Trial

Topic / Pathology

  • Multiple System Atrophy (MSA)

Objectives

To have more informations, click on the link below:

https://clinicaltrials.gov/ct2/show/NCT01146548?term=fluoxetine&cond=MS…

Sponsor

Toulouse Hospital

Investigator

Pr Olivier Rascol

Scientific publication(s)

  • Rascol O et al; MSA-FLUO Study Group. Fluoxetine for the Symptomatic Treatment of Multiple System Atrophy: The MSA-FLUO Trial. Mov Disord. 2021 Jul;36(7):1704-1711. 

    https://pubmed.ncbi.nlm.nih.gov/33792958/

Status

Published results

Participating centers

Share

Updated on 17 February 2023